Literature DB >> 16444863

Endogenous production of nitric oxide synthase inhibitors.

Shelagh Anthony1, James Leiper, Patrick Vallance.   

Abstract

Numerous reports have indicated that the plasma concentration of endogenously produced inhibitors of nitric oxide synthase are elevated in human disease states. In this review we discuss recent advances in our understanding of the enzymes responsible for the synthesis of these inhibitors.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16444863     DOI： 10.1191/1358863x05vm595oa

Source DB:  PubMed          Journal:  Vasc Med        ISSN： 1358-863X            Impact factor:   3.239


  12 in total

1.  Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Mark W Cunningham; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-08

Review 2.  AGXT2: a promiscuous aminotransferase.

Authors:  Roman N Rodionov; Natalia Jarzebska; Norbert Weiss; Steven R Lentz
Journal:  Trends Pharmacol Sci       Date:  2014-10-13       Impact factor: 14.819

3.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

4.  Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome.

Authors:  Tsin W Yeo; Daniel A Lampah; Emiliana Tjitra; Retno Gitawati; Christabelle J Darcy; Catherine Jones; Enny Kenangalem; Yvette R McNeil; Donald L Granger; Bert K Lopansri; J Brice Weinberg; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

Review 5.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

Review 6.  Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.

Authors:  Roman A Sukhovershin; Gautham Yepuri; Yohannes T Ghebremariam
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jul-Sep

7.  Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results.

Authors:  Folke Brinkmann; Beatrice Hanusch; Manfred Ballmann; Sebene Mayorandan; Alexander Bollenbach; Kristine Chobanyan-Jürgens; Kathrin Jansen; Anjona Schmidt-Choudhury; Nico Derichs; Dimitrios Tsikas; Thomas Lücke
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

8.  Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.

Authors:  Yuhee Ryu; Hae Jin Kee; Simei Sun; Young Mi Seok; Sin Young Choi; Gwi Ran Kim; Seung-Jung Kee; Marc Pflieger; Thomas Kurz; Hyung-Seok Kim; Myung Ho Jeong
Journal:  PLoS One       Date:  2019-03-04       Impact factor: 3.240

Review 9.  Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

Authors:  Shufen Chen; Na Li; Milani Deb-Chatterji; Qiang Dong; Jan T Kielstein; Karin Weissenborn; Hans Worthmann
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

10.  Kynurenines link chronic inflammation to functional decline and physical frailty.

Authors:  Reyhan Westbrook; Tae Chung; Jacqueline Lovett; Chris Ward; Humberto Joca; Huanle Yang; Mohammed Khadeer; Jing Tian; Qian-Li Xue; Anne Le; Luigi Ferrucci; Ruin Moaddel; Rafa de Cabo; Ahmet Hoke; Jeremy Walston; Peter M Abadir
Journal:  JCI Insight       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.